首页> Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases> Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis.

Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis.

导出 OA

翻译打印收藏纠错

第一作者： Jiawen,Deng

第一单位： Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Electronic address: dengj35@mcmaster.ca.

作者： Jiawen,Deng ^[1] ; Daniel,Rayner ^[2] ; Harikrishnaa B,Ramaraju ^[3] ; Umaima,Abbas ^[4] ; Cristian,Garcia ^[5] ; Kiyan,Heybati ^[6] ; Fangwen,Zhou ^[7] ; Emma,Huang ^[8] ; Ye-Jean,Park ^[5] ; Myron,Moskalyk ^[7]

作者单位： Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Electronic address: dengj35@mcmaster.ca. ^[1] Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada. ^[2] Virginia Commonwealth University School of Medicine, Virginia Commonwealth University, Richmond, VA, USA. ^[3] Schulich School of Medicine & Dentistry (Windsor Campus), University of Western Ontario, Windsor, Ontario, Canada. ^[4] Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. ^[5] Mayo Clinic Alix School of Medicine, Mayo Clinic (Rochester), Rochester, MN, USA. ^[6] Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada. ^[7] Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada. ^[8]

关键词 COVID-19 Fluvoxamine Meta-analysis SARS-CoV-2 Selective serotonin reuptake inhibitor

医学主题词人类(Humans);氟西汀(Fluoxetine);氟伏沙明(Fluvoxamine)

DOI 10.1016/j.cmi.2023.01.010

PMID 36657488

发布时间 2023-06-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交